These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cerebrospinal fluid monoamine metabolites and suicide. Jokinen J; Nordström AL; Nordström P Nord J Psychiatry; 2009; 63(4):276-9. PubMed ID: 19034712 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Mann JJ; Malone KM Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386 [TBL] [Abstract][Full Text] [Related]
11. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters. Westrin A; Niméus A Eur Psychiatry; 2003 Jun; 18(4):166-71. PubMed ID: 12814849 [TBL] [Abstract][Full Text] [Related]
12. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Samuelsson M; Jokinen J; Nordström AL; Nordström P Acta Psychiatr Scand; 2006 Jan; 113(1):44-7. PubMed ID: 16390368 [TBL] [Abstract][Full Text] [Related]
13. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628 [TBL] [Abstract][Full Text] [Related]
14. Rorschach ratings in depressed and suicidal patients with low levels of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Rydin E; Schalling D; Asberg M Psychiatry Res; 1982 Oct; 7(2):229-43. PubMed ID: 6183703 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Roy A; De Jong J; Linnoila M Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124 [TBL] [Abstract][Full Text] [Related]
16. Self-rated childhood emotional neglect and CSF monoamine indices in abstinent cocaine-abusing adults: possible implications for suicidal behavior. Roy A Psychiatry Res; 2002 Sep; 112(1):69-75. PubMed ID: 12379452 [TBL] [Abstract][Full Text] [Related]
17. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Faustman WO; Ringo DL; Faull KF Br J Psychiatry; 1993 Oct; 163():519-21. PubMed ID: 7504565 [TBL] [Abstract][Full Text] [Related]
18. Temperamental vulnerability and suicide risk after attempted suicide. Nordström P; Gustavsson P; Edman G; Asberg M Suicide Life Threat Behav; 1996; 26(4):380-94. PubMed ID: 9014268 [TBL] [Abstract][Full Text] [Related]
19. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Jones JS; Stanley B; Mann JJ; Frances AJ; Guido JR; Traskman-Bendz L; Winchel R; Brown RP; Stanley M Am J Psychiatry; 1990 Sep; 147(9):1225-7. PubMed ID: 1696794 [TBL] [Abstract][Full Text] [Related]
20. Aminergic studies and cerebrospinal fluid cations in suicide. Banki CM; Arató M; Kilts CD Ann N Y Acad Sci; 1986; 487():221-30. PubMed ID: 2436535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]